TMX1: Potential Drug Target Or Biomarker (G81542)

Target Name: TMX1

NCBI ID: G81542

TMX1

TMX1: Potential Drug Target Or Biomarker

TMX1 (Thioredoxin-related transmembrane protein 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the thioredoxin gene family, which includes proteins that are involved in the detoxification of harmful substances in the body. TMX1 is a transmembrane protein, which means that it spans the cell membrane and is associated with the cell's outer layer.

TMX1 is involved in a number of different biological processes in the body. One of its main functions is to help remove harmful substances from the body. This is accomplished through a process called detoxification, which involves the liver and other organs working together to break down and remove foreign substances that have entered the body. TMX1 is involved in this process by helping to transport the harmful substances to the liver for further processing and removal.

Another function of TMX1 is to regulate the production of reactive oxygen species (ROS) in the body. ROS are free radicals that can cause damage to cells and contribute to a number of diseases, including cancer. TMX1 helps to control the production of ROS by regulating the activity of a protein called NAD+, which is involved in the detoxification of ROS.

In addition to its role in detoxification and ROS regulation, TMX1 is also involved in a number of other biological processes in the body. For example, it is involved in the regulation of cell signaling, which is the process by which cells communicate with one another to carry out various tasks. TMX1 is also involved in the regulation of inflammation, which is the body's response to harmful substances in the body.

Given its involvement in a number of important biological processes, TMX1 is a potential drug target or biomarker for a variety of diseases. For example, TMX1 has been suggested as a potential therapeutic target for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition, TMX1 has also been shown to be involved in a number of diseases, including heart disease and liver disease, which may make it an attractive biomarker for these diseases as well.

While further research is needed to fully understand the role of TMX1 in the body and its potential as a drug target or biomarker, its potential as a therapeutic target is significant. The discovery and development of drugs that target TMX1 could lead to new treatments for a variety of diseases.

Protein Name: Thioredoxin Related Transmembrane Protein 1

Functions: May participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions

The "TMX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets